Real World Pediatric Oncology Rehabilitation in Italy ( ReWori )

NCT07368582 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 249

Last updated 2026-03-25

No results posted yet for this study

Summary

This observational study aims to describe changes in the functional abilities of children, adolescents and young adults with cancer who are undergoing physiotherapy or neuropsychomotor rehabilitation. This is real-world study aiming to describe normal rehabilitation pathways in many different hospitals or rehabilitation centres in Italy.

The primary research question is:

1\) What are the longitudinal changes in functional abilities among these patients receiving physiotherapy or neuropsychomotor rehabilitation?

The secondary research questions are:

1. What types of rehabilitation practices are implemented across AIEOP centres?
2. What are the rehabilitation needs among patients undergoing physiotherapy or neuropsychomotor rehabilitation?
3. How does health-related quality of life differ across the various stages of the rehabilitation pathway? Participants undergoing usual rehabilitation treatment are evaluated on their functional abilities on a monthly basis. If they agree to participate in this study, the main characteristics of the rehabilitation treatment and the monthly evaluation are collected.

Conditions

  • Pediatric Cancer
  • Pediatric Cancer Patients
  • Pediatric Oncology
  • Rehabilitation
  • Motor Outcomes
  • Physical Therapy

Interventions

OTHER

Rehabilitation intervention

This is an observational study, so it does not have a specific rehabilitation treatment protocol to be followed. The chort is followed with a periodic evaluation (monthly or every three month only for bone tumour diagnosis) during the period of the rehabilitation treatment

Sponsors & Collaborators

  • Associazione Italiana Ematologia Oncologia Pediatrica

    lead OTHER

Principal Investigators

  • Francesca Rossi Rossi, Master's degree · AOU Città della Salute e della Scienza di Torino - Ospedale Infantile Regina Margherita

Eligibility

Min Age
0 Months
Max Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-19
Primary Completion
2029-03-31
Completion
2029-09-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07368582 on ClinicalTrials.gov